Evidence map›Paper›PMID 34513595›Full record

ReviewWorld journal of clinical oncology2021

GOECP/SEOR clinical guidelines on radiotherapy for malignant pleural mesothelioma.

Javier Luna, Andrea Bobo, Joaquín José Cabrera-Rodriguez, María Pagola, Margarita Martín-Martín, María Ángeles González Ruiz, Miguel Montijano, Aurora Rodríguez, Lira Pelari-Mici, Almudena Corbacho and 2 more

Abstract readReview
In one paragraph

Review in World journal of clinical oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Analysis of radiotherapy planning images using colour blindness filters.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Javier LunaDepartment of Radiation Oncology, Institute of Oncohealth, Fundación Jiménez Díaz, Madrid 28040, Spain. jluna@fjd.es.
Andrea BoboDepartment of Radiation Oncology, Institution of Ruber Internacional Hospital, Madrid 28034, Spain.
Joaquín José Cabrera-RodriguezDepartment of Radiation Oncology, Hospital Universitario de Badajoz, Badajoz 06080, Spain.
María PagolaDepartment of Radiation Oncology, Institution of Onkologikoa/Hospital Universitario Donostia, San Sebastián 20014, Spain.
Margarita Martín-MartínDepartment of Radiation Oncology, Institution of Hospital Universitario Ramón y Cajal, Madrid 28034, Spain.
María Ángeles González RuizDepartment of Radiation Oncology, Institution of Hospital Universitario Virgen de la Macarena, Sevilla 41009, Spain.
Miguel MontijanoDepartment of Radiation Oncology, Institution of Genesis care Spain, Madrid 28005, Spain.
Aurora RodríguezDepartment of Radiation Oncology, Institution of Ruber Internacional Hospital, Madrid 28034, Spain.
Lira Pelari-MiciDepartment of Radiation Oncology, Institution of Hospital Universitario Ramón y Cajal, Madrid 28034, Spain.
Almudena CorbachoDepartment of Radiation Oncology, Institution of Hospital de Mérida, Mérida 06800, Spain.
Marta MorenoDepartment of Oncology, Institution of University Navarra, Clinical University, Pamplona 31008, Spain.
Felipe CouñagoDepartment of Radiation Oncology, Institution of Hospital Universitario Quirónsalud and Hospital LaLuz, European University of Madrid, Madrid 28028, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant pleural mesothelioma (MPM) is a rare tumor with poor prognosis and rising incidence. Palliative care is common in MPM as radical treatment with curative intent is often not possible due to metastasis or extensive locoregional involvement. Numerous therapeutic advances have been made in recent years, including the use of less aggressive surgical techniques associated with lower morbidity and mortality (

Indexed as

ChemotherapyMalignant pleural mesotheliomaRadiation techniquesRadiotherapyReradiationSurgery

Identifiers

PMID34513595
PMCPMC8394157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.